Fucoidan from Fucus vesiculosus Inhibits Inflammatory Response, Both In Vitro and In Vivo
Marine Drugs · 2023
DOI: 10.3390/md21050302 ↗Kurz gefasst
Fachartikel in der Zeitschrift Marine Drugs, 2023. Verfasst von Lingzhi Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Biotechnology and Health Sciences, Wuyi University, Jiangmen 529000, China. Hauptthemen laut MEDLINE: Fucus. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Norte 2020, INTERREG España-Portugal 2014-2020, Fundação para a Ciência e Tecnologia.
Abstract (Originalsprache)
Fucoidan has been reported to present diverse bioactivities, but each extract has specific features from which a particular biological activity, such as immunomodulation, must be confirmed. In this study a commercially available pharmaceutical-grade fucoidan extracted from Fucus vesiculosus, FE, was characterized and its anti-inflammatory potential was investigated. Fucose was the main monosaccharide (90 mol%) present in the studied FE, followed by uronic acids, galactose, and xylose that were present at similar values (3.8–2.4 mol%). FE showed a molecular weight of 70 kDa and a sulfate content of around 10%. The expression of cytokines by mouse bone-marrow-derived macrophages (BMDMs) revealed that the addition of FE upregulated the expression of CD206 and IL-10 by about 28 and 22 fold, respectively, in respect to control. This was corroborated in a stimulated pro-inflammatory situation, with the higher expression (60 fold) of iNOS being almost completely reversed by the addition of FE. FE was also capable of reverse LPS-caused inflammation in an in vivo mouse model, including by reducing macrophage activation by LPS from 41% of positive CD11C to 9% upon fucoidan injection. Taken together, the potential of FE as an anti-inflammatory agent was validated, both in vitro and in vivo.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Biotechnology and Health Sciences, Wuyi University, Jiangmen 529000, China.
- 3B's Research Group, I3Bs-Research Institute on Biomaterials, Biodegradables and Biomimetics, University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, Av…
- ICVS/3B's-PT Government Associate Laboratory, Braga, 4710-057 Guimarães, Portugal.
- State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau, China.
- LAQV-REQUIMTE, Department of Chemistry, University of Aveiro, Campus de Santiago, 3810-193 Aveiro, Portugal.
- CICECO, Department of Chemistry, University of Aveiro, Campus de Santiago, 3810-193 Aveiro, Portugal.
ORCID-Profile: Andreia S Ferreira, Cláudia Nunes, Manuel A Coimbra, Rui L Reis, Albino Martins, Tiago H Silva
Förderung
- Norte 2020
- INTERREG España-Portugal 2014-2020
- Fundação para a Ciência e Tecnologia
- National Natural Science Foundation of China
- European Regional Development Fund
- Portuguese Foundation for Science and Technology (FCT)
- FCT
- Natural Science Foundation of China
Zitieren
APA
Wang, L., Oliveira, C., Li, Q., Ferreira, A. S., Nunes, C., Coimbra, M. A., Reis, R. L., Martins, A., Wang, C., Silva, T. H., & Feng, Y. (2023). Fucoidan from Fucus vesiculosus Inhibits Inflammatory Response, Both In Vitro and In Vivo. Marine Drugs. https://doi.org/10.3390/md21050302
Vancouver
Wang L, Oliveira C, Li Q, Ferreira AS, Nunes C, Coimbra MA, et al. Fucoidan from Fucus vesiculosus Inhibits Inflammatory Response, Both In Vitro and In Vivo. Marine Drugs. 2023. doi:10.3390/md21050302
BibTeX
@article{Wang2023,
author = {Wang, Lingzhi and Oliveira, Catarina and Li, Qiu and Ferreira, Andreia S and Nunes, Cláudia and Coimbra, Manuel A and Reis, Rui L and Martins, Albino and Wang, Chunming and Silva, Tiago H and Feng, Yanxian},
title = {Fucoidan from Fucus vesiculosus Inhibits Inflammatory Response, Both In Vitro and In Vivo},
journal = {Marine Drugs},
year = {2023},
doi = {10.3390/md21050302}
}
EUVIMED